High-potency cannabis and the risk of psychosis.

The British Journal of Psychiatry : the Journal of Mental Science
Marta Di FortiRobin M Murray

Abstract

People who use cannabis have an increased risk of psychosis, an effect attributed to the active ingredient Delta 9-tetrahydrocannabinol (Delta 9-THC). There has recently been concern over an increase in the concentration of Delta 9-THC in the cannabis available in many countries. To investigate whether people with a first episode of psychosis were particularly likely to use high-potency cannabis. We collected information on cannabis use from 280 cases presenting with a first episode of psychosis to the South London & Maudsley National Health Service (NHS) Foundation Trust, and from 174 healthy controls recruited from the local population. There was no significant difference between cases and controls in whether they had ever taken cannabis, or age at first use. However, those in the cases group were more likely to be current daily users (OR = 6.4) and to have smoked cannabis for more than 5 years (OR = 2.1). Among those who used cannabis, 78% of the cases group used high-potency cannabis (sinsemilla, 'skunk') compared with 37% of the control group (OR 6.8). The finding that people with a first episode of psychosis had smoked higher-potency cannabis, for longer and with greater frequency, than a healthy control group is consiste...Continue Reading

References

Nov 11, 1995·Lancet
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·F M LewekeH M Emrich
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Jun 25, 2005·Schizophrenia Bulletin·Cécile HenquetJim van Os
Sep 28, 2005·Addiction·Neil Smith
Oct 11, 2007·Nature Reviews. Neuroscience·Robin M MurrayMarta Di Forti
Apr 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Celia J A Morgan, H Valerie Curran
Jun 3, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Jouko MiettunenJuha Veijola
Aug 30, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthijs G BossongRené S Kahn

❮ Previous
Next ❯

Citations

Mar 16, 2013·Analytical and Bioanalytical Chemistry·Mateus M BergamaschiMarilyn A Huestis
Feb 23, 2013·Cell and Tissue Research·Miriam Schneider
Mar 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sergiy SylantyevDmitri A Rusakov
Jun 25, 2013·Zebrafish·Muhammad T AkhtarMichael K Richardson
Jun 2, 2010·Schizophrenia Bulletin·Craig MorganRobin M Murray
Oct 24, 2012·Schizophrenia Bulletin·Simona A StiloCraig Morgan
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Alline Cristina CamposFrancisco Silveira Guimarães
Jun 3, 2014·Journal of Affective Disorders·Nathalie BallyJean-Michel Aubry
Mar 15, 2015·Current Addiction Reports·Samuel T WilkinsonDeepak Cyril D'Souza
Apr 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Euan M Lawson
Jun 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Cécile HenquetInez Myin-Germeys
Oct 5, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Cécile Henquet, Rebecca Kuepper
Oct 5, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Celia J A MorganH Valerie Curran
Feb 18, 2016·Schizophrenia Bulletin·Arianna MarconiEvangelos Vassos
Feb 23, 2011·International Review of Psychiatry·Anna WoodallCraig Morgan
Nov 27, 2015·Psychological Medicine·S RigucciP Dazzan
Jan 1, 2016·Schizophrenia Research·Marco ColizziMarta Di Forti
Feb 10, 2016·Biological Psychiatry·Valentina LorenzettiMurat Yücel
Feb 3, 2016·Frontiers in Psychiatry·Jean Lud Cadet, Veronica Bisagno
Jan 19, 2016·Drug and Alcohol Dependence·Amelia M ArriaKevin E O'Grady
Feb 8, 2016·Biological Psychiatry·F Markus LewekeCathrin Rohleder
Jan 29, 2016·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Corey J KellerJong H Yoon
Jul 4, 2013·Biological Psychiatry·Michael A P BloomfieldOliver D Howes
Jun 15, 2013·European Psychiatry : the Journal of the Association of European Psychiatrists·L SideliM Di Forti
Mar 6, 2013·Neuroscience and Biobehavioral Reviews·Zoran VukadinovicIvana Rosenzweig
Dec 12, 2012·Neurobiology of Disease·Atsushi SaitoAtsushi Kamiya
Aug 30, 2012·The Psychiatric Clinics of North America·Mary C ClarkeMary Cannon
May 5, 2012·Forensic Science International : Synergy·Yukari TsumuraKazumi Kurahashi
May 3, 2011·Neuroscience and Biobehavioral Reviews·Paola CasadioMarta Di Forti
Feb 4, 2011·Drug and Alcohol Dependence·James Richard BurgdorfRosalie Liccardo Pacula
Dec 22, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Anna KolliakouRobin M Murray
Sep 28, 2010·Neuroscience and Biobehavioral Reviews·Maria-Paz ViverosEdward J Wagner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.